Sean N. Tucker
2023
In 2023, Sean N. Tucker earned a total compensation of $1.1M as Chief Scientific Officer at Biota Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $121,414 |
---|---|
Option Awards | $428,840 |
Salary | $428,267 |
Stock Awards | $147,542 |
Other | $11,422 |
Total | $1,137,485 |
Tucker received $428.8K in option awards, accounting for 38% of the total pay in 2023.
Tucker also received $121.4K in non-equity incentive plan, $428.3K in salary, $147.5K in stock awards and $11.4K in other compensation.
Rankings
In 2023, Sean N. Tucker's compensation ranked 1,067th out of 2,983 executives tracked by ExecPay. In other words, Tucker earned more than 64.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,067 | 64th |
Manufacturing | 633 | 61st |
Chemicals And Allied Products | 431 | 52nd |
Drugs | 420 | 52nd |
Biological Products, Except Diagnostic Substances | 126 | 40th |
Tucker's colleagues
We found two more compensation records of executives who worked with Sean N. Tucker at Biota Pharmaceuticals in 2023.
News
Biota Pharmaceuticals CEO Andrei Floroiu's 2023 pay falls 48% to $1.9M
April 29, 2024
Biota Pharmaceuticals CEO Andrei Floroiu's 2022 pay jumps 49% to $3.6M
April 28, 2023
Biota Pharmaceuticals CEO Wouter Latour's 2020 pay jumps 280% to $2.8M
April 30, 2021
Biota Pharmaceuticals CEO Wouter Latour's 2019 pay slips 12% to $748K
April 24, 2020
Biota Pharmaceuticals CEO Joseph Patti's 2018 pay rises 12% to $1.2M
March 11, 2019